302 related articles for article (PubMed ID: 15717635)
1. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
2. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene.
Lee BC; Ahn SY; Doo HK; Yim SV; Lee HJ; Jin SY; Hong SJ; Lee SH; Kim SD; Seo JC; Leem KH; Chung JH
Neurosci Lett; 2004 Feb; 357(1):33-6. PubMed ID: 15036607
[TBL] [Abstract][Full Text] [Related]
4. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
5. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ
Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608
[TBL] [Abstract][Full Text] [Related]
8. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
Powell JJ; Fearon KC; Siriwardena AK; Ross JA
Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
Buraczynska M; Ksiazek P; Kubit P; Zaluska W
Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.
Chen YP; Pfab T; Slowinski T; Richter CM; Godes M; Hocher B
Chin Med J (Engl); 2006 May; 119(9):719-24. PubMed ID: 16701011
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10(-1082) (G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus.
Settin A; Ismail A; El-Magd MA; El-Baz R; Kazamel A
Autoimmunity; 2009 Jan; 42(1):50-5. PubMed ID: 19127455
[TBL] [Abstract][Full Text] [Related]
13. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
14. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
[TBL] [Abstract][Full Text] [Related]
15. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction.
Harcos P; Laki J; Kiszel P; Széplaki Z; Szolnoki Z; Kovács M; Melegh B; Széplaki G; Füst G; Blaskó B
Cytokine; 2006 Jan; 33(2):100-5. PubMed ID: 16473522
[TBL] [Abstract][Full Text] [Related]
16. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura.
Amoli MM; Thomson W; Hajeer AH; Calviño MC; Garcia-Porrua C; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2002 Jul; 29(7):1404-7. PubMed ID: 12136897
[TBL] [Abstract][Full Text] [Related]
18. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease.
Manzoli A; Andreotti F; Varlotta C; Mollichelli N; Verde M; van de Greef W; Sperti G; Maseri A
Cardiologia; 1999 Sep; 44(9):825-30. PubMed ID: 10609392
[TBL] [Abstract][Full Text] [Related]
19. Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.
Kim SD; Park JM; Kim IS; Choi KD; Lee BC; Lee SH; Hong SJ; Jin SY; Lee HJ; Hong MS; Chung JH; Lee TW; Ihm CG; Cho BS
Pediatr Nephrol; 2004 Mar; 19(3):295-9. PubMed ID: 14758530
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
